Analysis of Durability of Response to Avatrombopag (AVA) from a Phase 3b Multicenter, Randomized, Double-Blind, Placebo (PBO)-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of AVA for the Treatment of Pediatric Patients with ITC

Poster is available to registered attendees only via the ASH annual meeting virtual platform, as per congress regulations. 

Session Name: 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I

Session Date: Saturday, December 7, 2024

Presentation Time: 5:30 PM - 7:30 PM

Location: San Diego Convention Center, Halls G-H

Link to Published Abstract